Identification

Symbol
ABLX
ISIN code
BE 0003877942
Exchange / Market
Euronext
Handelssted
Brussels
Products family
Stocks
Market organization
EuronextBrussels
ICB
Biotechnology
Activity description

Ablynx specializes in the research and development of nanobodies (therapeutic proteins made from natural antibody fragments) intended to improve treatments for inflammatory diseases, thrombosis, cancer, and Alzheimer's disease. Net sales break down by type of income as follows:
- revenues from partnership agreements (94.6%);
- subsidies (5.4%).

Website address
www.ablynx.com
Issuer website
www.ablynx.com

Operation

IPO date
tir 09/03/2010
IPO type
New Issue Special Session
Catégorie
New Issue Special Session
Operation procedure

OFFER SHARES